Compare General Motors Company (GM) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Motors Company vs Tilray Brands Inc — how do they compare? General Motors Company trades at $82.5 (market cap $71.06B), while Tilray Brands Inc trades at $3.64 (market cap $549.01M). The key difference: General Motors Company is far larger — about 129.4× Tilray Brands Inc's market cap, and General Motors Company pays a 0.89% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Motors Company for 83 Days and Tilray Brands Inc for 31 Days on average.
| GM | TLRY | |
|---|---|---|
Market Cap | $71.06B | $549.01M |
Volume | 6,269,264 | 3,292,073 |
Sector | Consumer Cyclical | Health |
52-Week High | $90.30 | $21.00 |
52-Week Low | $55.35 | $3.57 |
Typical Hold Time | 83 Days | 31 Days |
Enterprise Value | $174.04B | $716.15M |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Motors (GM) trades at $80.99, down 1.24% on the day, amid a broader market downturn and weak Q3 2026 vehicle sales. The stock shows a bearish technical signal, with key support at $80. Fundamentally, GM's revenue dipped to $185.02B in 2025 with a thin net margin of 1.05%, though it has beaten EPS estimates for three consecutive quarters. Recent news highlights competitive pressure from Toyota and a 5.5% decline in Q3 U.S. sales, driven by EV softness.
GM faces headwinds from declining market share and high debt levels, but analyst consensus remains bullish with a $102.08 price target, implying significant upside. Investment appeal hinges on execution amid industry shifts, while risks include rising borrowing costs and intense competition. Cash flow stability offers some cushion, but profitability recovery is critical for sustained gains.
Tilray Brands (TLRY) trades at $3.715, down 1.72% on the day, as the stock continues to face significant pressure with bearish technical signals and fundamental challenges. The company reported a substantial net loss of $2.19 billion in 2025 despite $821 million in revenue, with negative cash flow from operations of $94.6 million. Recent earnings have consistently missed expectations, and technical indicators show a bearish trend with the stock trading near key support levels.
While TLRY shows attractive valuation metrics with P/S of 0.45 and P/B of 0.34, the company faces substantial execution risks amid persistent losses and negative cash flow. Analyst sentiment remains cautious with only 25% buy ratings, though the consensus price target of $65.01 suggests significant upside potential if the company can achieve profitability and growth targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About General Motors Company
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company lost its U.S. market share leader crown in 2021 with share down 280 basis points to 14.6%, but we expect GM to reclaim the top spot in 2022 as 2021 suffered from the chip shortage. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.
Read more on GM →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
